Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial

Overview of attention for article published in Trials, October 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Readers on

mendeley: 89 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 2,700 followers.

@GritGrowthCap @BrickOverton What about hormetic effect tho? I get the sense this is the type of guy who doesn’t cite his sources often and when he does it’s an even more questionable primary source 🫤 https://t.co/5uiVukXCtv

RT @BetatecHops: Xanthohumol acts as a prebiotic for intestinal microbiota. 👉 Check out this clinical trial: https://t.co/zT8mCUjKbi #ho…

Xanthohumol acts as a prebiotic for intestinal microbiota. 👉 Check out this clinical trial: https://t.co/zT8mCUjKbi #hops #prebiotic #antiinflammatory #antioxidant #microbiome https://t.co/2OYyNDPBFl

Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial. https://t.co/iGYaAtWTnN

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.